Kicker Ventures, WorldUpstart, and Kievit Scientific Announce Joint Launch of New Acceleration Program “Kicker AccelFit” Set for April 2024
Kicker Ventures (Menlo Park, USA, www.kickerventures.com), WorldUpstart (Philadelphia, USA, www.worldupstart.com), and Kievit Scientific LLC (Bala Cynwyd, USA, www.kievitsci.com) have teamed up to announce the launch of a new acceleration program, "Kicker AccelFit."
This groundbreaking initiative is specifically tailored to empower Japanese Life Sciences and MedTech companies aiming to establish a strong presence in the U.S. market.
Participants in this program will not only gain deep insights into the American healthcare market, business landscape, and regulatory requirements but will also leverage the extensive networks and resources offered by all three collaborating firms. The program is set to kick off in April 2024.
Mr. Masashi Kiyomine, Founder and Managing Partner of Kicker Ventures, commented, "This program began with the idea that we could provide further support to Japanese life sciences and healthcare companies entering the U.S. market. We hope to pool the strengths of our three companies to back the global success of the participating firms.”
Ms. Karina Sotnik, Founder & CEO of WorldUpstart, added, "Japan is a global leader in developing innovative technologies. We are excited about this collaboration and want to leverage our collective strengths to help Japanese companies double their odds of successfully entering the U.S. market.”
About Kicker Ventures
Kicker Venture is a venture capital fund investing in companies developing novel, transformational technology solutions to the world's healthcare problems. Kicker Venture is looking for transformational technology that breaks the status quo and profoundly improves patient outcomes and access to care. They invest in companies that make healthcare fundamentally better than what exists today—more advanced, equitable, empowered, and uplifting.
About WorldUpstart
WorldUpstart runs an international accelerator program for Life Sciences and MedTech companies looking to enter the US market. The US Market Gateway program is designed to help companies beat the odds, create a roadmap for expansion, and connect to the right players, partners, and investors.
About Kievit Scientific
Kievit Scientific assists companies from Japan in successfully entering the US market. Kievit Scientific specializes in life science businesses, including new drugs, personalized medicine, genomic science, cell biology, clinical medicine, and bioinformatics. Their services include market development, business development, and operational support.